My Account Log in

4 options

Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

EBSCOhost Academic eBook Collection (North America) Available online

View online

Ebook Central Academic Complete Available online

View online

NCBI Bookshelf Available online

View online

National Academies Press Available online

View online
Format:
Book
Author/Creator:
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation, issuing body.
Contributor:
Olson, Steve, 1956- contributor.
Claiborne, Anne B., contributor.
National Institute of Medicine (U.S.). Board on Health Sciences Policy, issuing body.
Language:
English
Subjects (All):
Drug monitoring.
Drug development--United States.
Drug development.
Drugs--United States--Design.
Drugs.
Pharmaceutical industry--United States--Quality control.
Pharmaceutical industry.
United States. Institutes of Health. National Center for Advancing Translational Sciences. Cures Acceleration Network.
United States.
Physical Description:
1 online resource (132 p.)
Edition:
1st ed.
Place of Publication:
Washington, District of Columbia : National Academies Press, [2012]
Language Note:
English
Summary:
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description.
Contents:
Introduction [The history and goals of CAN (Cures Acceleration Network)]
Approaches to accelerating translational science
Application of matching authority
Application of flexible research authority
Situating CAN within the drug development ecosystem
Final reflections on ways to maximize the goals of CAN.
Notes:
Description based upon print version of record.
Includes bibliographical references (pages 71).
Description based on print version record.
ISBN:
9780309261197
0309261198
9780309261173
0309261171
OCLC:
829421146

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account